Buys | $0 | 0 | 0 |
Sells | $555,108 | 1 | 100 |
Slate Path Capital LP | 10 percent owner | 0 | $0 | 1 | $555,108 | $-555,108 |
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's disease with vascular pathology; and Phase 1 trials diagnosed with schizophrenia in adults. It is also …
Over the last 12 months, insiders at Cyclerion Therapeutics, Inc. have bought $0 and sold $555,108 worth of Cyclerion Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Cyclerion Therapeutics, Inc. have bought $4.37M and sold $214,373 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 961,538 shares for transaction amount of $3M was made by Slate Path Capital LP (10 percent owner) on 2021‑06‑03.
2024-11-21 | Sale | Slate Path Capital LP | 10 percent owner | 357,880 11.132% | $1.55 | $555,108 | +111.97% | |
2023-08-09 | Sale | MCGUIRE TERRANCE | director | 8 0.0003% | $3.40 | $27 | -10.40% | |
2021-06-03 | Slate Path Capital LP | 10 percent owner | 961,538 0.1301% | $3.12 | $3M | -39.01% | ||
2021-06-03 | Hecht Peter M | Chief Executive Officer | 823,170 0.1171% | $3.28 | $2.7M | -39.01% | ||
2021-06-03 | MCGUIRE TERRANCE | director | 96,153 0.013% | $3.12 | $299,997 | -39.01% | ||
2021-05-06 | Hecht Peter M | Chief Executive Officer | 302,000 0.0413% | $2.43 | $733,860 | +6.43% | ||
2021-05-05 | Hecht Peter M | Chief Executive Officer | 398,001 0.0553% | $2.53 | $1.01M | +3.92% | ||
2021-05-04 | Hecht Peter M | Chief Executive Officer | 300,000 0.0415% | $2.29 | $687,000 | +14.22% | ||
2021-02-25 | Sale | Wright Christopher I | Chief Medical Officer | 2,637 0.0004% | $3.99 | $10,522 | -24.61% | |
2021-02-25 | Sale | Gjino Anjeza | Chief Financial Officer | 1,824 0.0003% | $4.00 | $7,296 | -24.61% | |
2020-12-28 | Sale | Currie Mark G | President and CSO | 20,107 0.0032% | $3.01 | $60,522 | +3.68% | |
2020-11-09 | Busch Andreas | Chief Innovation Officer | 125,000 0.0199% | $2.53 | $316,250 | +27.42% | ||
2020-11-06 | Sale | Huyett William | Chief Financial Officer | 3,827 0.0006% | $2.52 | $9,644 | +27.42% | |
2020-02-21 | Sale | Huyett William | Chief Financial Officer | 3,559 0.0007% | $5.12 | $18,222 | -16.49% | |
2019-12-30 | Sale | Currie Mark G | President | 25,000 0.0839% | $2.48 | $62,000 | +42.59% | |
2019-12-27 | Sale | Currie Mark G | President | 25,000 0.0917% | $2.55 | $63,750 | +51.97% | |
2019-11-15 | Busch Andreas | Chief Innovation Officer | 125,000 0.4616% | $1.82 | $227,500 | +114.44% | ||
2019-11-08 | Sale | Huyett William | Chief Financial Officer | 3,922 0.0155% | $2.05 | $8,040 | +103.16% | |
2019-04-08 | SCHULMAN AMY W | director | 626,117 0.1105% | $16.00 | $10.02M | -46.83% | ||
2019-04-08 | MCGUIRE TERRANCE | director | 626,117 0.1105% | $16.00 | $10.02M | -46.83% |
Slate Path Capital LP | 10 percent owner | 0 0% | $0 | 1 | 1 | <0.0001% |
Hecht Peter M | Chief Executive Officer | 2047698 75.558% | $5.18M | 4 | 0 | <0.0001% |
SCHULMAN AMY W | director | 604482 22.3048% | $1.53M | 1 | 0 | |
Busch Andreas | Chief Innovation Officer | 254704 9.3983% | $644,401.12 | 2 | 0 | +70.93% |
Currie Mark G | President and CSO | 251648 9.2856% | $636,669.44 | 1 | 3 |
$1,226,605 | 43 | -21.28% | $7.98M | |
$523,320 | 24 | 94.37% | $7.01M | |
$746,223 | 23 | -7.24% | $9.07M | |
$31,129 | 22 | -11.96% | $6.19M | |
$1,080,165 | 17 | -6.62% | $7.91M |
Increased Positions | 7 | +38.89% | 21,632 | +2.07% |
Decreased Positions | 5 | -27.78% | 682,328 | -65.44% |
New Positions | 5 | New | 10,747 | New |
Sold Out Positions | 2 | Sold Out | 527,340 | Sold Out |
Total Postitions | 20 | +11.11% | 381,943 | -63.37% |
Tyndall Capital Partners L P | $417.00 | 5.49% | 164,777 | 0 | 0% | 2024-12-31 |
Siren, L.L.C. | $294.00 | 3.87% | 116,155 | 0 | 0% | 2024-12-31 |
Geode Capital Management, Llc | $81.00 | 1.06% | 31,820 | -2,088 | -6.16% | 2024-12-31 |
Vanguard Group Inc | $59.00 | 0.78% | 23,490 | 0 | 0% | 2024-12-31 |
Blackrock, Inc. | $42.00 | 0.56% | 16,797 | 0 | 0% | 2024-12-31 |
Renaissance Technologies Llc | $27.00 | 0.35% | 10,611 | +10,611 | New | 2024-12-31 |
Ubs Group Ag | $24.00 | 0.32% | 9,667 | +9,522 | +6,566.9% | 2024-12-31 |
Fmr Llc | $12.00 | 0.16% | 4,740 | -152,896 | -96.99% | 2024-12-31 |
Tower Research Capital Llc (Trc) | $6.00 | 0.08% | 2,441 | +1,363 | +126.44% | 2024-12-31 |
Morgan Stanley | $2.00 | 0.02% | 649 | 0 | 0% | 2024-12-31 |